#IPO performance

News 📈 Stocks

BlossomHill Therapeutics Falls Post-$150M IPO in Cautious Biotech Debut

August 7, 2026 (46 days ago)

BlossomHill Therapeutics' post-IPO decline highlights investor caution toward cancer drugmakers, with the $150 million debut faltering on U.S. exchanges as biotech sentiment…

BLHL

🌍 US Read More →

News 📈 Stocks

India's Biggest 2026 IPO Dips Below Offer Price in Debut Trade

July 24, 2026 (60 days ago)

India's largest initial public offering of 2026 fell below its issue price in early trading, highlighting concerns about stretched valuations and subdued…

INDIPO.NS NIFTY50 INDA

🌍 IN Read More →